ClinicalTrials.Veeva

Menu

User Evaluation of BGM VGM77

I

Institut fur Diabetes Karlsburg GmbH

Status

Completed

Conditions

Diabetes

Treatments

Diagnostic Test: reference
Diagnostic Test: subject

Study type

Interventional

Funder types

Other

Identifiers

NCT06037512
2023_002

Details and patient eligibility

About

Performance Evaluation by the User of the Blood Glucose Monitoring System VGM77Compliant with DIN EN ISO 15197:2015

Enrollment

106 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female patients with hypo-, eu- or hyperglycaemia
  • The written informed consent had to be signed
  • The volunteers must be older than 18 years
  • The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

Exclusion criteria

  • Pregnancy or lactation
  • Acute or chronic diseases with the risk of aggravation by the measure
  • A current constitution that does not allow participating in the study
  • Participation in another study or activity with the blood glucose measuring system evaluated in the present study
  • Application of substances listed in Appendix A of DIN EN ISO 15197:2015

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

106 participants in 1 patient group

Subject glucometer measurement
Experimental group
Description:
Blood glucose measurement BGM for personal use
Treatment:
Diagnostic Test: subject
Diagnostic Test: reference

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems